Clinical Trials
3
Active:0
Completed:1
Trial Phases
2 Phases
Phase 2:2
Phase 4:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (66.7%)Phase 4
1 (33.3%)Methylphenidate for Apathy in Veterans With Parkinson's Disease
Phase 2
Not yet recruiting
- Conditions
- ApathyParkinson Disease
- Interventions
- Behavioral: Psychosocial intervention
- First Posted Date
- 2022-12-30
- Last Posted Date
- 2022-12-30
- Lead Sponsor
- Ralph H. Johnson VA Medical Center
- Target Recruit Count
- 60
- Registration Number
- NCT05669170
Dronabinol for Agitation in Dementia Crossover Trial
Phase 2
Withdrawn
- Conditions
- Dementia SevereBehavioral SymptomsAgitation,PsychomotorDementia Moderate
- Interventions
- First Posted Date
- 2022-11-10
- Last Posted Date
- 2024-07-05
- Lead Sponsor
- Ralph H. Johnson VA Medical Center
- Registration Number
- NCT05612711
- Locations
- 🇺🇸
Ralph H. Johnson VA Health Care System, Charleston, South Carolina, United States
Quetiapine Treatment for Post-Traumatic Stress Disorder (PTSD)
- First Posted Date
- 2005-10-12
- Last Posted Date
- 2008-02-21
- Lead Sponsor
- Ralph H. Johnson VA Medical Center
- Target Recruit Count
- 80
- Registration Number
- NCT00237393
- Locations
- 🇺🇸
NM VA Healthcare System, Albuquerque, New Mexico, United States
🇺🇸Ralph H. Johnson VAMC, Charleston, South Carolina, United States
News
No news found